Skip to Main content Skip to Navigation
Journal articles

Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease

Abstract : Background The impact of early treatment with immunomodulators (IM) and/or TNF antagonists on bowel damage in Crohn's disease (CD) patients is unknown. Aim To assess whether 'early treatment' with IM and/or TNF antagonists, defined as treatment within a 2-year period from the date of CD diagnosis, was associated with development of lesser number of disease complications when compared to 'late treatment', which was defined as treatment initiation after >2 years from the time of CD diagnosis. Methods Data from the Swiss IBD Cohort Study were analysed. The following outcomes were assessed using Cox proportional hazard modelling: bowel strictures, perianal fistulas, internal fistulas, intestinal surgery, perianal surgery and any of the aforementioned complications. Results The 'early treatment' group of 292 CD patients was compared to the 'late treatment' group of 248 CD patients. We found that 'early treatment' with IM or TNF antagonists alone was associated with reduced risk of bowel strictures [hazard ratio (HR) 0.496, P = 0.004 for IM; HR 0.276, P = 0.018 for TNF antagonists]. Furthermore, 'early treatment' with IM was associated with reduced risk of undergoing intestinal surgery (HR 0.322, P = 0.005), and perianal surgery (HR 0.361, P = 0.042), as well as developing any complication (HR 0.567, P = 0.006). Conclusions Treatment with immunomodulators or TNF antagonists within the first 2 years of CD diagnosis was associated with reduced risk of developing bowel strictures, when compared to initiating these drugs >2 years after diagnosis. Furthermore, early immunomodulators treatment was associated with reduced risk of intestinal surgery, perianal surgery and any complication.
Document type :
Journal articles
Complete list of metadatas

https://hal.univ-lorraine.fr/hal-01680008
Contributor : Ngere Ul <>
Submitted on : Wednesday, January 10, 2018 - 12:45:28 PM
Last modification on : Tuesday, October 13, 2020 - 10:46:04 AM

Links full text

Identifiers

Collections

Citation

E. Safroneeva, S. R. Vavricka, N. Fournier, V. Pittet, L. Peyrin-Biroulet, et al.. Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease. Alimentary Pharmacology & Therapeutics (Suppl), 2015, 42 (8), pp.977 - 989. ⟨10.1111/apt.13363⟩. ⟨hal-01680008⟩

Share

Metrics

Record views

114